Hangzhou Chengyuan Biotechnology Co., Ltd.
RootPath Genomics
Hangzhou Chengyuan Biotechnology Co., Ltd.
Biotech/Healthcare
RootPath Genomics is a synthetic biology and gene and cell therapy services provider. Built around a high-throughput single-cell analysis platform enabled by microfluidics, the company develops diagnostic and companion diagnostic products for a range of diseases.
Latest round: Series C (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.